Target intelligence / Profile preview

Putative cyclin-Y-like protein 3 (CCNYL3)

Target
CCNYL3
Molecular classification
Other
01

Overview

CCNYL3, or putative cyclin-Y-like protein 3, is a predicted human protein encoded by the CCNYL3 gene, based on homology to cyclin Y family members. UniProt describes the gene and its product as “putative,” with no functional annotation, no reported biological functions, and no established links to cell signaling, transcription, or disease[5]. Unlike cyclin Y (CCNY), which is well-studied and involved in cell cycle regulation, signal transduction, and cancer, CCNYL3 is uncharacterized and lacking experimental validation, with no disease associations or evidence of clinical significance in the literature. If you need information about CCNY (cyclin Y) instead—which is an established regulator of cell cycle and signaling—please request it specifically, as CCNY is substantially annotated and experimentally characterized, while CCNYL3 is not[1][3][5].

Other names
CCNYL3Putative cyclin-Y-like protein 3

Beyond the preview

Go deeper on Putative cyclin-Y-like protein 3 (CCNYL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Putative cyclin-Y-like protein 3 (CCNYL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call